Clinical trial · Observational
Factors Affecting BAT Activation in PET/CT
Factors Affecting Brown Adipose Tissue (BAT) Activation in Cancer Patients Undergoing 18F-FDG-PET/CT
NCT05577299CI-TRIAL-00061431unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the present study is to evaluate the factors affecting BAT activation in 18F-FDG-PET/CT in different tumours
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Factors Affecting BAT Activation in PET/CT | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| PET/CT | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- the main factors that affect appearance of BAT in PET/CT studies and try to avoid these factors.
- timeFrame
- from 7/2019 to 7/2022
- description
- the amount and SUV max of the detected BAT activation in PET scan correlated with the patient prognosis.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * This study will include all patients presented with different types of tumors. * patients conscious to provide informed consent Exclusion Criteria: * • Patients who have contraindications to PET/CT scanning such as: a blood glucose level higher than 150-200 mg/dL, uncontrolled diabetics. * Intolerance of PET/CT due to claustrophobia will be excluded from the study. * Patients under age of 18
References
Publications (0)
Data not yet available
No reference posted for this study.